LifeMD (NASDAQ:LFMD) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.01) by 900 percent. This is a 200 percent decrease over earnings of $0.06 per share from the same period last year. The company reported quarterly sales of $62.200 million which missed the analyst consensus estimate of $66.343 million by 6.24 percent. This is a 22.77 percent increase over sales of $50.662 million the same period last year.